SOURCE: DC Brands International, Inc.

November 07, 2007 08:00 ET

DC Brands Adding to Sales Team

DENVER, CO--(Marketwire - November 7, 2007) - DC Brands International (PINKSHEETS: DCBR) announces they are meeting with three experienced sales professionals about joining the team.

DC Brands President and CEO Richard Pearce said, "Jim Randall, VP of Sales, has the credibility within the industry to bring the best of the best to the table. He has committed to getting the foundation of a first-class sales team in place by the end of the year, and his recent additions prove that. All candidates we are meeting with bring almost immediate business from major retailers and distributors."

Randall said, "We will continue to need many more top sales people, but I believe these additions will give us the core team of true industry professionals we need to get through the second quarter."

About DC Brands International:

DC Brands International, a publicly traded company under the ticker symbol (PINKSHEETS: DCBR), specializes in and manufactures unique energy drink brands. Established in 1998, DC Brands went public in 2005, and the company's first product, Dickens Energy Cider, launched in 2002 after a lengthy process in developing its distinctive flavor and packaging. Following the success of Dickens Energy Cider, the company chose to expand its product line with a beverage that filled the substantial NASCAR niche. With more than 75 million loyal fans, the NASCAR demographic presented an attractive opportunity to become one of the few racecar-themed energy drinks in the marketplace. Following much due diligence, research and testing, Turn Left Energy Drink recently came to fruition.

For more information on DC Brands International, visit their website at www.TurnLeftEnergy.com and DickensEnergyCider.com.

Note: Except for the historical information contained herein, this news release contains forward-looking statements that involve substantial risks and uncertainties. Among the factors that could cause actual results or timelines to differ materially are risks associated with research and clinical development, regulatory approvals, supply capabilities and reliance on third-party manufacturers, product commercialization, competition, litigation, and the other risk factors listed from time to time in reports filed by DC Brands International with the Securities and Exchange Commission, including but not limited to risks described under the caption "Important Factors That May Affect Our Business, Our Results of Operation and Our Stock Price." The forward-looking statements contained in this news release represent judgments of the management of DC Brands International as of the date of this release. DC Brands International and its managers and agents undertake no obligation to publicly update any forward-looking statements.

Contact Information